|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash from operating activities | |||||
| Provision for credit losses - loans | |||||
| Provision for credit losses - off-balance sheet credit exposures | |||||
| Provision (credit) for credit losses - off-balance sheet credit exposures | |||||
| Net (accretion) amortization of securities | |||||
| Depreciation and amortization | |||||
| Net realized (gain) loss on sales of securities available for sale | |||||
| Net realized gain on sales of securities available for sale | |||||
| Net unrealized gain on discontinued financial derivative | |||||
| Stock dividends on restricted investments | |||||
| Net increase on other investment | |||||
| Loss on sale of loans | |||||
| Loss on disposal of fixed assets | |||||
| Appreciation on bank-owned life insurance | |||||
| ESOP compensation expense for allocated shares | |||||
| Loss (gain) on sale other real estate owned | |||||
| Fair value adjustment on other real estate owned | |||||
| Stock-based compensation | |||||
| Deferred income tax expense (benefit) | |||||
| Loss on fair value adjustment of fair value hedges | |||||
| Net change in | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued expenses and other liabilities | |||||
| Net Cash from Operating Activities | |||||
| Investing Activities | |||||
| Net change in interest bearing deposits in banks | |||||
| Purchases | |||||
| Sales | |||||
| Maturities, prepayments and calls | |||||
| Purchases of restricted investments | |||||
| Net decrease in net investment in direct financing leases | |||||
| Redemptions of restricted investments | |||||
| Purchases of other investment | |||||
| Loan originations and principal collections, net | |||||
| Net decrease (increase) in net investment in direct financing leases | |||||
| Proceeds from sale of loans, originally classified as loans held for investment | |||||
| Proceeds from sales of other real estate owned | |||||
| Additions of premises and equipment | |||||
| Net Cash from Investing Activities | |||||
| Financing Activities | |||||
| Net (decrease) increase in deposits | |||||
| Advances from FHLB and other borrowings | |||||
| Payments on FHLB and other borrowings | |||||
| Cash dividends declared and paid | |||||
| Purchases of treasury stock | |||||
| Net Cash used for Financing Activities | |||||
| Net Change in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents at Beginning of Period | |||||
| Cash and Cash Equivalents at End of Period | |||||
Loading...